Indeed, Costa et al. recently demonstrated that CD26 is an important cell surface protein in human breast cancer, promoting the differentiation and activation of CD25 + FoxP3 T-cells, and thereby directly inhibiting the proliferation of effector T-cells [10]. This evidence concerns the gene DPP4 and breast carcinoma.